PlainPharmaWatch

CMS Open Payments · Tool

Prenosis Inc. vs Monteris Medical Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Prenosis Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 7,679, versus 1,107 for the other company. Its single largest recorded recipient represents 87.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Prenosis Inc.
HHI 7,679 · top recipient 87.4%
Ranked #202 of 1,838 companies by HHI
Monteris Medical Corporation
HHI 1,107 · top recipient 23.5%
Ranked #990 of 1,838 companies by HHI

Payment Overview

Company A

Prenosis Inc.

Total Payments
$474.5K
% of Industry
0.0%
Transactions
56
Avg per Transaction
$8.5K
Recipients
46
Avg per Recipient
$10.3K
Payment Types
3
Top Payment Type
Consulting Fee
Total Payments
$475.8K
% of Industry
0.0%
Transactions
506
Avg per Transaction
$940.36
Recipients
433
Avg per Recipient
$1.1K
Payment Types
4
Top Payment Type
Long-Term Medical Supply or Device Loan

Highlighted values indicate the higher figure for each metric.

Total payments compared

Prenosis Inc. vs Monteris Medical Corporation - total reported payments in CMS Open Payments PY2024

Monteris Medical Corporation$475.8KPrenosis Inc.$474.5K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Prenosis Inc.

Consulting Fee $142.6K

98.7%

Travel and Lodging $1.7K

1.2%

Food and Beverage $190.18

0.1%

Monteris Medical Corporation

Long-Term Medical Supply or Device Loan $97.3K

49.3%

Consulting Fee $68.9K

34.9%

Food and Beverage $21.4K

10.8%

Travel and Lodging $9.9K

5.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Prenosis Inc.

  1. 1

    NATHAN SHAPIRO

    $126,228.45 · 16 txns

  2. 2

    SEAN COLLINS

    $9,401.02 · 8 txns

  3. 3

    FARHAN ALI

    $1,980.00 · 1 txns

  4. 4

    KEVIN KLAUER

    $742.60 · 1 txns

  5. 5

    WILLIAM BRAD WEIR

    $475.00 · 2 txns

Monteris Medical Corporation

  1. 1

    Stanford Health Care

    $46,355.00 · 1 txns

  2. 2

    Ut Md Anderson Cancer Center

    $26,035.00 · 1 txns

  3. 3

    Virginia Mason Medical Center

    $24,892.00 · 1 txns

  4. 4

    Peter Fecci

    $24,838.33 · 32 txns

  5. 5

    Albert H Kim

    $11,106.62 · 12 txns

Summary Comparison

Metric Prenosis Inc. Monteris Medical Corporation
Total Payments $474.5K $475.8K
% of Industry Total 0.0% 0.0%
Transaction Count 56 506
Avg per Transaction $8.5K $940.36
Recipient Count 46 433
Avg per Recipient $10.3K $1.1K
Payment Type Count 3 4
Top Payment Type Consulting Fee Long-Term Medical Supply or Device Loan

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.